Fundraising Fox

Axil Capital

Venture capital

Tokyo · Seed–Late Stage · 7 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Axil Capital pursues a strategy of creating value in the life sciences venture ecosystem by identifying and nurturing transformational biotech and healthcare technologies across the full investment spectrum. The firm diversifies its portfolio across biopharmaceuticals, platform technologies, medical devices, digital health, and healthcare services. The investment thesis emphasizes establishing synergies between Japan's biotech ecosystem and global markets to build commercially viable enterprises with sustainable returns while addressing transformational needs in healthcare and medical innovation.

Invests inBiotechDigital HealthMedical DevicesGlobalJapanTokyo

Source: firm website, verified Aug 5, 2026.

Stage
Seed–Late Stage
HQ
Tokyo, JP
Instruments
Equity
Founded
2017

Team · 7 people

from the firm's website & public directories
Frederick Shane· Managing Partner
Hiroshi Gonaikawa· Partnerin
Joon Paek· Principal
Kimihito Usui· Senior Principal
Yoshitake Maeda· Venture Partner

Frequently asked questions

What stage does Axil Capital invest at?
Axil Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Axil Capital focus on?
Axil Capital focuses on Biotech, Digital Health, Medical Devices.
Where is Axil Capital located?
Axil Capital is headquartered in Tokyo, JP.

Images

Axil Capital photo

Co-investors · 2

Firms observed investing alongside Axil Capital, from public investor directories.

Similar investors

Featured in lists